About MoMelan Technologies
MoMelan Technologies is a Healthcare company based in Cambridge (United States) founded in 2009, and was acquired by KCI in December 2012. Skin grafting technology for dermatological diseases and wound care. MoMelan Technologies has raised $8.75 million across 3 funding rounds from investors including Solventum, LaunchCapital and Mass Medical Angels. Its chief executive, as recorded, is Sameer Sabir. Its focus areas include Life Sciences, Dermatology, Medical Devices and Therapeutic Devices. Its legal entity is MoMelan Technologies Inc. Its competitors include Suneva Medical, LifeCell and Longevity Biomedical; 2 of its 3 listed competitors have raised funding.
Company details
MoMelan Technologies was founded in 2009 in Cambridge, United States, to develop and commercialize epidermal grafting technology for dermatological diseases and chronic wounds. A device was created to increase skin graft surface area, enabling coverage of larger body areas, initially for vitiligo at Massachusetts General Hospitals Wellman Center. Potential applications include scars and other graft-dependent conditions. The company was acquired by Kinetic Concepts (KCI) in December 2012.
- Headquarters Cambridge, United States
- Stage Acquired
- SectorsHealthcare
- Website momelan.com
- Social LinkedIn
- Acquired by KCI (Dec 2012)
- Legal Name Momelan Technologies Inc
Funding Insights of MoMelan Technologies
MoMelan Technologies has successfully raised a total of $8.75M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $4.79 million completed in July 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $8.75M
- Total Rounds 3
- Last Round Series A — $4.79M
- First Round $1.08M
(Jun 2010)
- Investors Count 2
All 3 funding rounds of MoMelan Technologies with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul 2011 | $4.79M | Series A | – | – | – |
| Apr 2011 | $2.88M | Seed | – | – | – |
| Jun 2010 | $1.08M | Seed | – | – |
3 investors in total: 3 institutional.
Investors in MoMelan Technologies
MoMelan Technologies has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Solventum, LaunchCapital and Mass Medical Angels.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
VC firm investing in seed & early stage companies in the US | launchcapital.com | New Haven, United States | ||
Seed stage investments are made in life sciences and healthcare. | 2010 | massmedangels.com | Boston, United States | |
Healing solutions are provided by KCI in the healthcare field. | 1991 | mykci.com | Saint Paul, United States |
Investor details for MoMelan Technologies
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of MoMelan Technologies
1 people are tracked at MoMelan Technologies (1 in leadership).
| Name | Role | Group |
|---|---|---|
Sameer Sabir | CEO & President | Leadership |
Complete people profiles for MoMelan Technologies
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of MoMelan Technologies
4 dated milestones of MoMelan Technologies across 3 years, from founding to its latest funding, stage changes and deals.
- Founded MoMelan Technologies is founded.
- Funding First funding round of $1.1M.
- Funding Latest funding round, Series A, of $4.8M.
- Exit Acquired by KCI.
Competitors of MoMelan Technologies
MoMelan Technologies has 3 listed competitors in our database, 2 of them funded. They include Suneva Medical, LifeCell and Longevity Biomedical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| sunevamedical.com | 2009 | San Diego, United States | $154.8M | 94 | Novel aesthetic products for regenerative markets are developed and commercialized. | |
| lifecell.com | 1986 | United States | $14M | Tissue repair products for regenerative medicine are developed and marketed. | ||
| longevitybiomedical.com | 2022 | Bothell, United States | Longevity Biomedical offers innovative products and services to promote healthier living and longevity. |
Detailed competitors of MoMelan Technologies
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Dermatology
3 companies that operate in the same segment as MoMelan Technologies (Dermatology) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Neurotoxin products for aesthetic and therapeutic skin treatments are developed. | 2002 | Newark, New Jersey, United States | USD 154.56 M | USD 234.04 M | 597 | |
Diagnostic tests for cancer prognosis are provided. | 2008 | Friendswood, Texas, United States | USD 61.97 M | USD 344.23 M | 761 | |
Adhesive patch biopsies for skin cancer detection are provided. | 1996 | San Diego, California, United States | USD 24.37 M | USD 15.3 M | 259 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Momelan Technologies
Complete news archive for MoMelan Technologies
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about MoMelan Technologies
MoMelan Technologies was founded in 2009 and raised its 1st funding round 1 year after it was founded.
MoMelan Technologies is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Sameer Sabir is the CEO of MoMelan Technologies, as recorded in our data.
MoMelan Technologies is a funded company, having raised a total of $8.75M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.08M, raised on Jun 2010.
MoMelan Technologies was founded in 2009 in Cambridge, United States, to develop and commercialize epidermal grafting technology for dermatological diseases and chronic wounds. A device was created to increase skin graft surface area, enabling coverage of larger body areas, initially for vitiligo at Massachusetts General Hospitals Wellman Center. Potential applications include scars and other graft-dependent conditions. The company was acquired by Kinetic Concepts (KCI) in December 2012.
MoMelan Technologies's top competitors include Suneva Medical, LifeCell and Longevity Biomedical.
MoMelan Technologies has 3 investors. Key investors include Solventum, LaunchCapital, and Mass Medical Angels.
MoMelan Technologies operates through Momelan Technologies Inc.
Yes. MoMelan Technologies was acquired by KCI in December 2012.